More from the company: Swedish site will participate in the Foxy-5 phase 1b study

More from the company: Swedish site will participate in the Foxy-5 phase 1b study

Press release from Companies: Svenskt onkologicenter kommer att delta i fas 1b-studien med Foxy-5

Press release from Companies: Svenskt onkologicenter kommer att delta i fas 1b-studien med Foxy-5

Press release from Companies: WntResearch has submitted phase 1b study application

Press release from Companies: WntResearch har lämnat in tillståndsansökan för fas 1b-studien

Press release from Companies: WntResearch har lämnat in tillståndsansökan för fas 1b-studien

Press release from Companies: WntResearch has submitted phase 1b study application

Press release from Companies: WntResearch har lämnat in tillståndsansökan för fas 1b-studien

Press release from Companies: WntResearch har lämnat in tillståndsansökan för fas 1b-studien

Press release from Companies: Preclinical toxicology studies for Foxy-5 are completed

Press release from Companies: Preclinical toxicology studies for Foxy-5 are completed